SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on March 17, 2017. The report discloses a material event under Item 8.01 (Other Events). Note: The request metadata referenced "Streamex Corp.," but the filing text explicitly identifies the registrant as BioSig Technologies, Inc.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses solely on a corporate event rather than financial performance.
Material Changes and Events
- Strategic Partnership: On March 17, 2017, the Company announced a strategic partnership with Mayo Clinic.
- Documentation: A press release detailing the partnership is included as Exhibit 99.1 and incorporated by reference.
Guidance, Outlook, and Risks
The filing text does not contain specific financial guidance, management commentary on future performance, risk factors, or contingencies beyond the announcement of the partnership. The full details of the partnership's impact are contained in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific terms and scope of the Mayo Clinic partnership.
- Verify the strategic fit of the partnership with BioSig Technologies' core business model.
- Check subsequent filings for any financial impact or milestones resulting from this agreement.